← Back to Search

Behavioral Intervention

C-SMART for Brain Cancer (C-SMART Trial)

N/A
Recruiting
Led By Sarah E Braun, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a new online therapy (C-SMART) helps people with brain cancer and mild memory problems.

Who is the study for?
This trial is for adults with a glioma brain tumor who have finished radiation therapy at least a month ago. They should be able to perform daily activities well (KPS score ≥ 80), speak English, and show some cognitive decline compared to before their illness. People can't join if they can't attend online sessions, understand the study, or have severe sleep problems.
What is being tested?
The C-SMART program is being tested in this study. It's delivered via telehealth and combines cognitive strategies, mindfulness techniques, and rehabilitation therapy aimed at helping patients with mild neurocognitive disorders due to gliomas.
What are the potential side effects?
Since C-SMART involves non-invasive therapies like cognitive exercises and mindfulness training rather than drugs or surgery, significant side effects are not expected. However, participants may experience fatigue or emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 11 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Determine acceptability of C-SMART intervention - Satisfaction
Determine acceptability of C-SMART intervention - Satisfaction - Recommendation
Determine feasibility of C-SMART - Data collection procedures
+4 more
Secondary study objectives
Determine feasibility of C-SMART research procedures - Patient reported outcome completion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: C-SMARTExperimental Treatment1 Intervention
C-SMART intervention will be provided via telehealth. Participants will complete in-person neurocognitive testing (baseline, post-intervention) as well as surveys (baseline, post-session, post-intervention) via secure email link. Exit interviews will be conducted by Zoom.

Find a Location

Who is running the clinical trial?

American Cancer Society, Inc.OTHER
231 Previous Clinical Trials
109,639 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
716 Previous Clinical Trials
22,888,426 Total Patients Enrolled
American Psychological FoundationOTHER
18 Previous Clinical Trials
1,901 Total Patients Enrolled

Media Library

C-SMART (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05984667 — N/A
Gliomas Research Study Groups: C-SMART
Gliomas Clinical Trial 2023: C-SMART Highlights & Side Effects. Trial Name: NCT05984667 — N/A
C-SMART (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05984667 — N/A
~44 spots leftby Sep 2026